Exp Clin Endocrinol Diabetes 2019; 127(07): 455-460
DOI: 10.1055/a-0581-4870
Article
© Georg Thieme Verlag KG Stuttgart · New York

Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients

Karel Kostev
1   Epidemiology, QuintilesIMS, Frankfurt, Germany
,
Alexander Lucas
2   Faculty of Medicine, University of Marburg, Marburg, Germany
,
Louis Jacob
3   Faculty of Medicine, University of Paris 5, Paris, France
› Author Affiliations
Further Information

Publication History

received 06 January 2018
revised 16 February 2018

accepted 22 February 2018

Publication Date:
12 March 2018 (online)

Abstract

Background The goal of this study was to analyze the frequency of blood pressure (BP) and estimated glomerular filtration rate (eGFR) testing in type 2 diabetes mellitus (T2DM) patients followed in general and diabetological practices in Germany.

Methods The study included individuals who had at least two concultations due to T2DM diagnosis (ICD-10: E11) between January and December 2016. Patients were followed in 557 general and diabetological practices. The primary outcome was the frequency of BP and eGFR testing in T2DM patients in 2016. The association between several demographic and clinical variables and the odds of receiving≥2 BP and≥1 eGFR tests in the year 2016 was analyzed using multivariate logistic regression models.

Results A total of 43,509 individuals were available for analysis. The mean age of the population was 68.6 years (SD=12.4 years). The mean number of measurements was 2.9 (SD=3.5) for BP and 0.4 (SD=1.1) for eGFR. 52.3% of patients were tested at least twice for BP and 15.3% of them at least once for eGFR in 2016. Older patients, individuals followed in diabetological practices, people receiving antihyperglycemic medications, and those affected by chronic conditions (i. e. hypertension, renal complications, or neuropathy) displayed higher odds of receiving≥2 BP and≥1 eGFR tests, whereas patients with a diabetes duration of>1 year displayed lower odds.

Conclusions The frequency of BP and eGFR testing was low in T2DM patients in Germany in 2016. Several demographic and clinical variables were associated with this frequency.

 
  • References

  • 1 International Diabetes Federation: Diabetes Atlas. 7th ed. 2015. Accessed 20th August 2017. URL: http://www.diabetesatlas.org/across-the-globe.html
  • 2 Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertens. Dallas Tex 1979 2001; 37: 1053-1059
  • 3 Sharma AM, Wittchen H-U, Kirch W. et al. High prevalence and poor control of hypertension in primary care: Cross-sectional study. J. Hypertens 2004; 22: 479-486
  • 4 Rückert I-M, Schunk M, Holle R. et al. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol 2012; 11: 50
  • 5 Hoffmann F, Haastert B, Koch M. et al. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 2011; 26: 1634-1640
  • 6 Bailey RA, Wang Y, Zhu V. et al. Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014; 7: 415
  • 7 Narres M, Claessen H, Droste S. et al. The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review [Internet]. PLoS ONE 2016; 11 DOI: doi: 10.1371/journal.pone.0147329. [PMID: 26812415PMCID: PMC4727808]
  • 8 Thomas C, Thomas L. Renal Failure—Measuring the Glomerular Filtration Rate.. Dtsch Ärztebl Int 2009; 106: 849-854
  • 9 Cederholm J, Gudbjörnsdottir S, Eliasson B. et al. NDR: Blood pressure and risk of cardiovascular diseases in type 2 diabetes: Further findings from the Swedish National Diabetes Register (NDR-BP II). J Hypertens 2012; 30: 2020-2030
  • 10 Kassenärztliche Vereinigung Westfalen-Lippe. Medizinische Versorgungsinhalte DMP Diabetes mellitus Typ 2 [Internet]. 2017
  • 11 Raum E, Lietzau S, Stegmaier C. et al. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 2008; 17: 485-494
  • 12 Du Y, Heidemann C, Rosario AS. et al. Changes in diabetes care indicators: Findings from German National Health Interview and Examination Surveys 1997–1999 and 2008–2011. BMJ Open Diabetes Res Care 2015; 3: e000135
  • 13 Laxy M, Knoll G, Schunk M. et al. Quality of diabetes care in Germany improved from 2000 to 2007 to 2014, but improvements diminished since 2007. Evidence from the population-based KORA studies. PloS One 2016; 11: e0164704
  • 14 Dombrowski S, Kostev K. Use of Electronic Medical Records in the Epidemiological Research [Internet]. Cuvillier Verlag; 2017
  • 15 Kostev K, Gläser S, Jacob L. Seasonality of insulin use in German outpatients with diabetes: A retrospective analysis. J Diabetes Sci Technol 2017; DOI: 10.1177/1932296817703994.. [PMID: 28420259]
  • 16 Jacob L, von Vultee C, Kostev K. Prescription patterns and the cost of antihyperglycemic drugs in patients with type 2 diabetes mellitus in Germany. J Diabetes Sci Technol 2017; 11: 123-127
  • 17 Kostev K, Rockel T, Jacob L. Prescription patterns and disease control in type 2 diabetes mellitus patients in nursing home and home care settings: A retrospective analysis in Germany. J Diabetes Sci Technol 2017; DOI: doi: 10.1177/1932296817710477. [PMID: 28539088]
  • 18 Jacob L, Adam-Schnepf L, Kostev K. Persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients with dementia in Germany. J Diabetes Sci Technol 2017; DOI: 10.1177/1932296817719090.. [PMID: 28681637]
  • 19 De Berardis G, Pellegrini F, Franciosi M. et al. Quality of care and outcomes in type 2 diabetic patients: A comparison between general practice and diabetes clinics. Diabetes Care 2004; 27: 398-406
  • 20 Renard LM, Bocquet V, Vidal-Trecan G. et al. Adherence to international follow-up guidelines in type 2 diabetes: A longitudinal cohort study in Luxembourg. PLOS ONE 2013; 8: e80162
  • 21 Chew BH, Ghazali SS, Ismail M. et al. Age≥ 60 years was an independent risk factor for diabetes-related complications despite good control of cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Gerontol 2013; 48: 485-491
  • 22 Huang ES, Laiteerapong N, Liu JY. et al. Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study. JAMA Intern Med 2014; 174: 251-258
  • 23 Campbell NRC, Gilbert RE, Leiter LA. et al. Hypertension in people with type 2 diabetes. Can Fam Physician 2011; 57: 997-1002
  • 24 Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J. et al. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol 2013; 14: 46
  • 25 Salvotelli L, Stoico V, Perrone F. et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. J Diabetes Complications 2015; 29: 1066-1070